IRIS
NARDONE, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.835
AS - Asia 3.287
NA - Nord America 2.529
SA - Sud America 509
AF - Africa 35
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.203
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.249
US - Stati Uniti d'America 2.461
SG - Singapore 1.180
IE - Irlanda 716
CN - Cina 637
HK - Hong Kong 575
BR - Brasile 433
VN - Vietnam 415
IT - Italia 409
KR - Corea 192
DE - Germania 161
IN - India 84
GB - Regno Unito 73
JP - Giappone 58
AT - Austria 36
NL - Olanda 31
BD - Bangladesh 30
FR - Francia 27
CA - Canada 26
AR - Argentina 25
FI - Finlandia 24
MX - Messico 24
GR - Grecia 19
BE - Belgio 16
IQ - Iraq 15
PL - Polonia 15
EC - Ecuador 14
PK - Pakistan 14
ZA - Sudafrica 13
CZ - Repubblica Ceca 11
ID - Indonesia 11
TR - Turchia 11
UA - Ucraina 10
UZ - Uzbekistan 10
VE - Venezuela 10
SE - Svezia 9
CO - Colombia 8
ES - Italia 7
IR - Iran 7
PE - Perù 7
SA - Arabia Saudita 7
MA - Marocco 6
CL - Cile 5
CR - Costa Rica 5
EG - Egitto 5
KZ - Kazakistan 5
OM - Oman 5
AU - Australia 4
DK - Danimarca 4
IL - Israele 4
LT - Lituania 4
UY - Uruguay 4
BO - Bolivia 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
PH - Filippine 3
RO - Romania 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
HN - Honduras 2
KE - Kenya 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NR - Nauru 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 13.203
Salva come PNG Salva come JPEG
Città #
Moscow 1.907
Dublin 716
Hong Kong 566
Santa Clara 542
Singapore 505
San Jose 423
Seoul 192
Ashburn 174
Chandler 168
Hefei 153
Ho Chi Minh City 124
Hanoi 111
Naples 104
Dallas 87
Beijing 83
Roxbury 74
Princeton 73
The Dalles 69
Bremen 61
Bengaluru 60
Cambridge 57
São Paulo 41
Munich 38
New York 38
Jacksonville 30
Los Angeles 30
Dong Ket 26
Da Nang 22
Council Bluffs 20
Nuremberg 19
Rio de Janeiro 18
Brussels 16
Medford 16
Boardman 15
Orem 15
Amsterdam 14
Falkenstein 14
Vienna 14
Belo Horizonte 13
Des Moines 13
Frankfurt am Main 13
Atlanta 12
Aversa 12
Haiphong 12
Helsinki 11
Hillsboro 11
Milan 11
Warsaw 10
Brno 9
Hải Dương 9
Newark 9
Tashkent 9
Bắc Ninh 8
Campinas 8
Goiânia 8
Lappeenranta 8
Mexico City 8
Tokyo 8
Ann Arbor 7
Chennai 7
Dhaka 7
Johannesburg 7
Phoenix 7
Curitiba 6
Manchester 6
Montreal 6
Rome 6
Solofra 6
Stockholm 6
Thái Bình 6
Tianjin 6
Brooklyn 5
Guayaquil 5
Lima 5
London 5
Ninh Bình 5
Phủ Lý 5
Salerno 5
San Francisco 5
San José 5
Thái Nguyên 5
Viamão 5
Vũng Tàu 5
Baghdad 4
Bari 4
Brasília 4
Camaçari 4
Criciúma 4
Hangzhou 4
Huế 4
Ipatinga 4
Jakarta 4
Jinan 4
Lahore 4
Nha Trang 4
Nova Iguaçu 4
Phú Thọ 4
Piscataway 4
Porto Alegre 4
Praia Grande 4
Totale 7.048
Salva come PNG Salva come JPEG
Nome #
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study 184
Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery 163
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 162
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy 158
Delta radiomics: a systematic review 158
CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT Trial 150
4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy 150
Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy 149
MRI Radiomics in Prostate Cancer: A Reliability Study 149
Secondary Complications in COVID-19 Patients: A Case Series 146
Radiomics as a new frontier of imaging for cancer prognosis: A narrative review 146
Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review 142
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 141
"RT STRIKES BACK": Radiotherapy in Ultra Elderly with Cutaneous Basal Cell Carcinoma 139
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 139
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 139
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 138
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 137
Non-Oncological Radiotherapy: A Review of Modern Approaches 132
Delta-radiomics increases multicentre reproducibility: a phantom study 132
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 131
Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment 127
Identification of perineural invasion at imaging staging as a novel potential risk factor in rectal cancer: A case report 126
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 124
Quantitative Evaluation of the Lymph Node Metastases in the Head and Neck Malignancies Using Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Mapping: A Bicentric Study 123
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 123
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 122
Artificial intelligence applied to image-guided radiation therapy (IGRT): a systematic review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 122
Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis 120
Diagnostic Value of Contrast-Enhanced Ultrasound in Differentiating Malignant from Benign Small Renal Masses After CT/MRI 118
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk 118
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer 117
Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool 117
Robustness of Radiomics in Pre-Surgical Computer Tomography of Non-Small-Cell Lung Cancer 117
Abemaciclib for malignant pleural mesothelioma 116
Choosing the optimal gated window for defining target volume in lung stereotactic ablative radiotherapy 116
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology 114
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 114
A critical review on oligometastatic disease: a radiation oncologist’s perspective 113
Total Severity Score (TSS) comparison in vaccinated and unvaccinated patients during the fourth wave (December 2021 - January 2022) of COVID-19 in Italy 113
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 112
Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients 110
Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative review 108
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 108
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 107
Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy 107
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 106
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 106
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 105
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures 104
Are you planning to be a radiation oncologist? A survey by the young group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 103
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy 103
Feasibility of stereotactic ablative reirradiation in breast cancer patient undergoing palbociclib: A case report 101
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus 100
Genetic profiling in radiotherapy: a comprehensive review 98
Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation 98
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 98
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: A role for autophagy 98
Prognostic Value of Sarcopenia in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer Undergoing Radiotherapy 97
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 97
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 95
“Aging and epigenetic implications in radiotherapy: The promise of BNCT” 95
The role of coronary artery calcification score in lung cancer patients 94
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 94
Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients 93
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 90
Effects of CT FOV displacement and acquisition parameters variation on texture analysis features 89
Delayed enhancement in differential diagnosis of salivary gland neoplasm 88
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 88
Temporal muscle thickness and survival in patients with amyotrophic lateral sclerosis 87
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 87
Texture Analysis in Cancer Prognosis 86
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 86
Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal End Point? 86
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma 85
Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature? 85
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 84
Could PD-1/PDL1 immune checkpoints be linked to HLA signature? 83
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 83
Pitfalls and differential diagnosis on adrenal lesions: current concepts in CT/MR imaging: a narrative review 83
Mood Disorder in Cancer Patients Undergoing Radiotherapy During the COVID-19 Outbreak 83
The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer 82
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 81
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 81
The role of radiation therapy and systemic therapies in elderly with breast cancer 80
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 80
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients 79
Feasibility of ultra-central stereotactic ablative irradiation in lung cancer undergoing nivolumab: A case report 79
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 78
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 78
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 77
Lumbosacral Plexopathy in Pelvic Radiotherapy: An Association not to be Neglected; A Systematic Review 77
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer 77
ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement 76
Does multiparametric US improve diagnostic accuracy in the characterization of small testicular masses? 76
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation 76
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 76
Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases 75
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer (Front. Oncol., (2021), 11, (744956), 10.3389/fonc.2021.744956) 74
The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique 74
Totale 10.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 1 21 28
2021/2022405 3 1 0 1 46 6 50 21 11 76 30 160
2022/20231.041 83 11 31 52 108 52 19 51 575 8 32 19
2023/2024570 39 29 26 36 202 32 18 16 15 6 46 105
2024/20252.424 12 52 34 74 376 352 322 222 332 343 153 152
2025/20268.865 339 504 466 395 742 4.868 502 450 388 211 0 0
Totale 13.480